PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naïve type 2 diabetes mellitus patients

Objective: PB-119, a PEGylated exenatide injection, is a once-weekly glucagon-like peptide-1 receptor agonist. In the present study, we aimed to evaluate the effects of PB-119 on insulin resistance and beta-cell function in Chinese patients with type 2 diabetes mellitus (T2DM) to uncover its antidia...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xu, Song, Ling, Zhang, Yuanhui, Li, Haiyan, Cui, Cheng, Liu, Dongyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539604/
https://www.ncbi.nlm.nih.gov/pubmed/37781697
http://dx.doi.org/10.3389/fphar.2023.1088670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539604/
https://www.ncbi.nlm.nih.gov/pubmed/37781697
http://dx.doi.org/10.3389/fphar.2023.1088670

Ejemplares similares